- Home
- SMJF vs ANVS Comparison
SMJF vs ANVS Comparison
Compare SMJF & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMJF | ANVS |
|---|---|---|
| Founded | 1988 | 2008 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.8M | 111.3M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SMJF | ANVS |
|---|---|---|
| Price | $5.43 | $2.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 375.6K | ★ 437.7K |
| Earning Date | 01-01-0001 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $12,533,617.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $174.84 | ★ N/A |
| Revenue Growth | ★ 1.51 | N/A |
| 52 Week Low | $4.25 | $1.11 |
| 52 Week High | $7.00 | $5.50 |
Technical Indicators
Market Signals| Indicator | SMJF | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 54.40 | 35.11 |
| Support Level | $5.10 | $2.29 |
| Resistance Level | $5.59 | $2.65 |
| Average True Range (ATR) | 0.24 | 0.20 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 50.00 | 17.67 |
Price Performance
Historical ComparisonAbout SMJF SMJ International Holdings Inc. Class A Ordinary Shares
SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.